TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.7430
-0.0127 (-1.68%)
At close: Jul 31, 2026, 4:00 PM EDT
0.7486
+0.0056 (0.75%)
After-hours: Jul 31, 2026, 7:34 PM EDT
TScan Therapeutics Employees
As of March 31, 2026, TScan Therapeutics had 139 total employees, including 138 full-time and 1 part-time employees. The number of employees decreased by 3 or -2.11% since the number was last reported on December 31, 2025.
Employees
139
Change
-3
Growth
-2.11%
Revenue / Employee
$65,727
Profits / Employee
-$894,281
Market Cap
48.56M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 139 | -3 | -2.11% | 138 | 1 |
| Dec 31, 2025 | 142 | -53 | -27.18% | 142 | 0 |
| Dec 31, 2024 | 195 | 41 | 26.62% | 194 | 1 |
| Dec 31, 2023 | 154 | 16 | 11.59% | 154 | 0 |
| Dec 31, 2022 | 138 | 33 | 31.43% | 137 | 1 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 118 |
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| BeyondSpring | 44 |
| INmune Bio | 21 |
| Filana Therapeutics | 20 |
| Instil Bio | 17 |
| Edesa Biotech | 17 |
TCRX News
- 4 days ago - TScan Therapeutics doses first patient in ALLOHA-2 trial - TheFly
- 4 days ago - TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies - GlobeNewsWire
- 4 weeks ago - TScan Therapeutics Transcript: H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - Transcripts
- 5 weeks ago - TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - GlobeNewsWire
- 5 weeks ago - TScan Therapeutics Transcript: KOL event - Transcripts
- 5 weeks ago - TScan Therapeutics Press release: KOL event - Filings
- 5 weeks ago - TScan Therapeutics Slides: KOL event - Filings
- 5 weeks ago - TScan Therapeutics presents data from Cohort C of ALLOHA trial - TheFly